Proof of harm in anti-dumping cases relies on multiple market indicators
Commercial lawyer Abdullah Al-Dosari says proving harm in anti-dumping cases requires assessing sales, profits, market share, and prices, not just one metric.
Antidumping cases hinge on demonstrating harm, according to commercial lawyer Abdullah Al-Dosari. Al-Dosari shared his insights on the matter with Al-Ikhbariya Radio, emphasizing that proving harm in such cases is not a matter of assessing just one metric. Instead, multiple indicators must be considered. He listed sales, profits, production, market share, and prices as key indicators, highlighting the importance of evidence from various aspects of the market.
Furthermore, Al-Dosari mentioned that Article 22 of the Executive Regulations for the Commercial Remedies in International Trade Law outlines additional indicators for proving harm, including return on investment, capacity utilization, cash flow, inventory levels, employment rates, and the ability to raise capital. Investigations into anti-dumping cases also factor in the impact of imports on local prices, such as significant price differences or reductions.
Thus, relying on a single indicator is insufficient; a comprehensive analysis involving multiple indicators is essential. The executive regulations for commercial remedies in international trade law provide the necessary framework for handling anti-dumping, countervailing, and safeguard measures, detailing the procedures, complaint mechanisms, and investigation processes involved.
Written by urgent.news from Ajel English's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
